Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.66 USD | +3.87% | +0.90% | +36.14% |
Business Summary
Number of employees: 187
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Small Molecule Therapeutics
100.0
%
| 47 | 100.0 % | 79 | 100.0 % | +67.84% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 47 | 100.0 % | 79 | 100.0 % | +67.84% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nello Mainolfi
FOU | Founder | 45 | 31/08/15 |
Bruce Jacobs
DFI | Director of Finance/CFO | 54 | 14/07/19 |
Juliet Williams
CTO | Chief Tech/Sci/R&D Officer | - | 04/05/21 |
Kevin Dushney
CTO | Chief Tech/Sci/R&D Officer | - | 02/02/21 |
Jared Gollob
CTO | Chief Tech/Sci/R&D Officer | 60 | 31/08/18 |
Vijay Sabesan
CTO | Chief Tech/Sci/R&D Officer | 51 | 05/12/21 |
Jeremy Chadwick
COO | Chief Operating Officer | 61 | 21/05/23 |
Investor Relations Contact | - | 30/06/23 | |
Aimee Mishkin
LAW | General Counsel | - | 31/03/20 |
Melissa Brody
PRN | Corporate Officer/Principal | - | 01/11/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 03-27 |
Joanna Horobin
BRD | Director/Board Member | 69 | 30/04/18 |
John Maraganore
BRD | Director/Board Member | 60 | 16/01/22 |
Elena Ridloff
BRD | Director/Board Member | 44 | 11/03/21 |
Pamela Esposito
BRD | Director/Board Member | 50 | 03/09/20 |
Jeffrey Albers
BRD | Director/Board Member | 52 | 30/06/20 |
Leigh Morgan
BRD | Director/Board Member | - | 07/07/22 |
Victor Sandor
BRD | Director/Board Member | 57 | 02/11/22 |
Nello Mainolfi
FOU | Founder | 45 | 31/08/15 |
Director/Board Member | 35 | 29/02/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 61,358,262 | 60,515,185 ( 98.63 %) | 0 | 98.63 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.14% | 2.13B | |
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- KYMR Stock
- Company Kymera Therapeutics, Inc.